Ledger.Open graph →

SEC Form D · filed April 28, 2017

National Biopharma, LLC

Offering

$2.0M

Sold

—

Exemption

Rule 506(c)

Industry

Biotechnology

Location

CHESAPEAKE, OH

Type

—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (14)

Kulvinder Somra · Chesapeake, OHExec · Director Ken Carter · VANCOUVER, British Columbia, CanadaExec · Director Michelle Renick · Chesapeake, OHExec Ric Widdifield · Chesapeake, OHDirector Ken Mcmillian · Chesapeake, OHExec · Director Dakota Collins · Chesapeake, OHExec · Director Linda Marshall · Chesapeake, OHExec · Director Kulvinder Somra · Chesapeake, OHExec · Director Ken Carter · Chesapeake, OHExec · Director Michelle Renick · Chesapeake, OHExec Ric Widdifield · Chesapeake, OHDirector Ken Mcmillian · Chesapeake, OHExec · Director Dakota Collins · Chesapeake, OHExec · Director Linda Marshall · Chesapeake, OHExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗